He recalled being 'so scared' and wondering if he was ever 'going to be able to walk again' after the 2013 diagnosis.

There’s a spring in former Carson High School teacher Phil Brady’s step now that he doesn’t have to rely on his wheelchair ...

Could NfL and GFAP redefine how clinicians track progression in MS? Dr Mark Freedman joins Dr Anne Cross to explain the ...

Treatment with fenebrutinib in a 2-year open-label extension study led to significantly reduced disease-related inflammatory activity in those with relapsing MS, according to speaker at ECTRIMS ...

In a cohort of Black and Hispanic individuals with relapsing MS, baseline comorbidities had no significant effect on the ...

A Queensland couple face the prospect of selling their home in the search for a life-changing surgery for their 22-month-old ...

Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR ...

Kazia Therapeutics Limited , an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized ...

Philips has expanded its partnership with Cortechs.ai to integrate the company’s AI-driven neuroimaging analytics directly into Philips’ MR s ...

Health technology company Royal Philips announced an extended partnership with Cortechs.ai, a company specializing in ...

MS and MOGAD share similar symptoms but are two biologically distinct conditions, with different immune signatures, a study ...

Explore the concept of the MS prodrome, a period with subtle symptoms before multiple sclerosis onset. Learn about early ...